Velmetia
sitagliptin, metformin
Keep this leaflet. You may need to read it again.
If you have any further questions, ask your doctor, pharmacist, or nurse.
This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4.
What Velmetia is and what it is used for
What you need to know before you take Velmetia
How to take Velmetia
Possible side effects
How to store Velmetia
Contents of the pack and other information
Velmetia contains two different medicines called sitagliptin and metformin.
sitagliptin belongs to a class of medicines called DPP-4 inhibitors (dipeptidyl peptidase-4 inhibitors)
metformin belongs to a class of medicines called biguanides.
They work together to control blood sugar levels in adult patients with a form of diabetes called ‘type 2 diabetes mellitus’. This medicine helps to increase the levels of insulin produced after a meal and lowers the amount of sugar made by your body.
Along with diet and exercise, this medicine helps lower your blood sugar. This medicine can be used alone or with certain other medicines for diabetes (insulin, sulphonylureas, or glitazones).
What is type 2 diabetes?
Type 2 diabetes is a condition in which your body does not make enough insulin, and the insulin that your body produces does not work as well as it should. Your body can also make too much sugar. When this happens, sugar (glucose) builds up in the blood. This can lead to serious medical problems like heart disease, kidney disease, blindness, and amputation.
if you are allergic to sitagliptin or metformin or any of the other ingredients of this medicine (listed in section 6).
if you have severely reduced kidney function
if you have uncontrolled diabetes, with e.g. severe hyperglycaemia (high blood glucose), nausea, vomiting, diarrhoea, rapid weight loss, lactic acidosis (see “Risk of lactic acidosis” below) or ketoacidosis. Ketoacidosis is a condition in which substances called ‘ketone bodies’
accumulate in the blood and which can lead to diabetic pre-coma. Symptoms include stomach pain, fast and deep breathing, sleepiness or your breath developing an unusual fruity smell.
if you have a severe infection or are dehydrated
if you are going to have an X-ray where you will be injected with a dye. You will need to stop taking Velmetia at the time of the X-ray and for 2 or more days after as directed by your doctor, depending on how your kidneys are working
if you have recently had a heart attack or have severe circulatory problems, such as ‘shock’ or
breathing difficulties
if you have liver problems
if you drink alcohol to excess (either every day or only from time to time)
if you are breast-feeding
Do not take Velmetia if any of the above apply to you and talk with your doctor about other ways of managing your diabetes. If you are not sure, talk to your doctor, pharmacist or nurse before taking Velmetia.
Cases of inflammation of the pancreas (pancreatitis) have been reported in patients receiving Velmetia (see section 4).
If you encounter blistering of the skin it may be a sign for a condition called bullous pemphigoid. Your doctor may ask you to stop Velmetia.
Risk of lactic acidosis
Velmetia may cause a very rare, but very serious side effect called lactic acidosis, particularly if your kidneys are not working properly. The risk of developing lactic acidosis is also increased with uncontrolled diabetes, serious infections, prolonged fasting or alcohol intake, dehydration (see further information below), liver problems and any medical conditions in which a part of the body has a reduced supply of oxygen (such as acute severe heart disease).
If any of the above apply to you, talk to your doctor for further instructions.
Symptoms of lactic acidosis include:
vomiting
stomach ache (abdominal pain)
muscle cramps
a general feeling of not being well with severe tiredness
difficulty in breathing
reduced body temperature and heartbeat
Lactic acidosis is a medical emergency and must be treated in a hospital. Talk to your doctor or pharmacist before taking Velmetia:
if you have or have had a disease of the pancreas (such as pancreatitis)
if you have or have had gallstones, alcohol dependence or very high levels of triglycerides (a form of fat) in your blood. These medical conditions can increase your chance of getting pancreatitis (see section 4)
if you have type 1 diabetes. This is sometimes called insulin-dependent diabetes
if you have or have had an allergic reaction to sitagliptin, metformin, or Velmetia (see section 4)
if you are taking a sulphonylurea or insulin, diabetes medicines, together with Velmetia, as you may experience low blood sugar levels (hypoglycaemia). Your doctor may reduce the dose of your sulphonylurea or insulin
If you need to have major surgery you must stop taking Velmetia during and for some time after the procedure. Your doctor will decide when you must stop and when to restart your treatment with Velmetia.
If you are not sure if any of the above apply to you, talk to your doctor or pharmacist before taking Velmetia.
During treatment with Velmetia, your doctor will check your kidney function at least once a year or more frequently if you are elderly and/or if you have worsening kidney function.
Children and adolescents below 18 years should not use this medicine. It is not effective in children and adolescents between the ages of 10 and 17 years. It is not known if this medicine is safe and effective when used in children younger than 10 years.
If you need to have an injection of a contrast medium that contains iodine into your bloodstream, for example, in the context of an X-ray or scan, you must stop taking Velmetia before or at the time of the injection. Your doctor will decide when you must stop and when to restart your treatment with Velmetia.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. You may need more frequent blood glucose and kidney function tests, or your doctor may need to adjust the dosage of Velmetia. It is especially important to mention the following:
medicines (taken by mouth, inhalation, or injection) used to treat diseases that involve inflammation, like asthma and arthritis (corticosteroids)
medicines which increase urine production (diuretics)
medicines used to treat pain and inflammation (NSAID and COX-2-inhibitors, such as ibuprofen and celecoxib)
certain medicines for the treatment of high blood pressure (ACE inhibitors and angiotensin II
receptor antagonists)
specific medicines for the treatment of bronchial asthma (β-sympathomimetics)
iodinated contrast agents or alcohol-containing medicines
certain medicines used to treat stomach problems such as cimetidine
ranolazine, a medicine used to treat angina
dolutegravir, a medicine used to treat HIV infection
vandetanib, a medicine used to treat a specific type of thyroid cancer (medullary thyroid cancer)
digoxin (to treat irregular heartbeat and other heart problems). The level of digoxin in your
blood may need to be checked if taking with Velmetia.
Avoid excessive alcohol intake while taking Velmetia since this may increase the risk of lactic acidosis (see section “Warnings and precautions”).
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. You should not take this medicine during pregnancy or if you are breast-feeding. See section 2, Do not take Velmetia.
This medicine has no or negligible influence on the ability to drive and use machines. However, dizziness and drowsiness have been reported with sitagliptin, which may affect your ability to drive or use machines.
Taking this medicine in combination with medicines called sulphonylureas or with insulin can cause hypoglycaemia, which may affect your ability to drive and use machines or work without safe foothold.
This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially
‘sodium-free’.
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
Take one tablet:
twice daily by mouth
with meals to lower your chance of an upset stomach.
Your doctor may need to increase your dose to control your blood sugar.
If you have reduced kidney function, your doctor may prescribe a lower dose.
You should continue the diet recommended by your doctor during treatment with this medicine and take care that your carbohydrate intake is equally distributed over the day.
This medicine alone is unlikely to cause abnormally low blood sugar (hypoglycaemia). When this medicine is used with a sulphonylurea medicine or with insulin, low blood sugar can occur and your doctor may reduce the dose of your sulphonylurea or insulin.
If you take more than the prescribed dosage of this medicine, contact your doctor immediately. Go to the hospital if you have symptoms of lactic acidosis such as feeling cold or uncomfortable, severe nausea or vomiting, stomach ache, unexplained weight loss, muscular cramps, or rapid breathing (see
section “Warnings and precautions”).
If you miss a dose, take it as soon as you remember. If you do not remember until it is time for your next dose, skip the missed dose and go back to your regular schedule. Do not take a double dose of this medicine.
Continue to take this medicine as long as your doctor prescribes it so you can continue to help control your blood sugar. You should not stop taking this medicine without talking to your doctor first. If you stop taking Velmetia, your blood sugar may rise again.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
STOP taking Velmetia and contact a doctor immediately if you notice any of the following serious side effects:
Severe and persistent pain in the abdomen (stomach area) which might reach through to your
back with or without nausea and vomiting, as these could be signs of an inflamed pancreas (pancreatitis).
Velmetia may cause a very rare (may affect up to 1 in 10,000 people), but very serious side effect called lactic acidosis (see section “Warnings and precautions”). If this happens, you must stop taking Velmetia and contact a doctor or the nearest hospital immediately, as lactic acidosis may lead to
coma.
If you have a serious allergic reaction (frequency not known), including rash, hives, blisters on the skin/peeling skin and swelling of the face, lips, tongue, and throat that may cause difficulty in breathing or swallowing, stop taking this medicine and call your doctor right away. Your doctor may prescribe a medicine to treat your allergic reaction and a different medicine for your diabetes.
Some patients taking metformin have experienced the following side effects after starting sitagliptin: Common (may affect up to 1 in 10 people): low blood sugar, nausea, flatulence, vomiting Uncommon (may affect up to 1 in 100 people): stomach ache, diarrhoea, constipation, drowsiness
Some patients have experienced diarrhoea, nausea, flatulence, constipation, stomach ache or vomiting when starting the combination of sitagliptin and metformin together (frequency is common).
Some patients have experienced the following side effects while taking this medicine with a sulphonylurea such as glimepiride:
Very common (may affect more than 1 in 10 people): low blood sugar Common: constipation
Some patients have experienced the following side effects while taking this medicine in combination with pioglitazone:
Common: swelling of the hands or legs
Some patients have experienced the following side effects while taking this medicine in combination with insulin:
Very common: low blood sugar Uncommon: dry mouth, headache
Some patients have experienced the following side effects during clinical studies while taking sitagliptin alone (one of the medicines in Velmetia) or during post-approval use of Velmetia or sitagliptin alone or with other diabetes medicines:
Common: low blood sugar, headache, upper respiratory infection, stuffy or runny nose and sore throat, osteoarthritis, arm or leg pain
Uncommon: dizziness, constipation, itching Rare: reduced number of platelets
Frequency not known: kidney problems (sometimes requiring dialysis), vomiting, joint pain, muscle pain, back pain, interstitial lung disease, bullous pemphigoid (a type of skin blister)
Some patients have experienced the following side effects while taking metformin alone:
Very common: nausea, vomiting, diarrhoea, stomach ache and loss of appetite. These symptoms may happen when you start taking metformin and usually go away
Common: a metallic taste
Very rare: decreased vitamin B12 levels, hepatitis (a problem with your liver), hives, redness of the skin (rash) or itching
If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister and the carton after 'EXP'. The expiry date refers to the last day of the month.
Do not store above 30C.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
The active substances are sitagliptin and metformin.
Each Velmetia 50 mg/850 mg film-coated tablet (tablet) contains sitagliptin phosphate monohydrate equivalent to 50 mg of sitagliptin and 850 mg of metformin hydrochloride.
Each Velmetia 50 mg/1,000 mg film-coated tablet (tablet) contains sitagliptin phosphate monohydrate equivalent to 50 mg of sitagliptin and 1,000 mg of metformin hydrochloride.
The other ingredients are:
Tablet core: microcrystalline cellulose (E460), povidone K 29/32 (E1201), sodium lauryl sulfate, and sodium stearyl fumarate.
Film coating: poly(vinyl alcohol), macrogol 3350, talc (E553b), titanium dioxide (E171), iron oxide red (E172), and iron oxide black (E172).
Velmetia 50 mg/850 mg film-coated tablets are capsule-shaped, pink film-coated tablets with
“515” debossed on one side.
Velmetia 50 mg/1,000 mg film-coated tablets are capsule-shaped, red film-coated tablets with
“577” debossed on one side.
Opaque blisters (PVC/PE/PVDC and aluminium). Packs of 14, 28, 56, 60, 112, 168, 180,
196 film-coated tablets, multi-packs containing 196 (2 packs of 98) and 168 (2 packs of
84) film-coated tablets. Pack of 50 x 1 film-coated tablets in perforated unit dose blisters. Not all pack sizes may be marketed.
Merck Sharp & Dohme B.V. Waarderweg 39
2031 BN Haarlem The Netherlands
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:
MSD Belgium
Tél/Tel: +32 (0)27766211
UAB “Merck Sharp & Dohme”
Tel. +370 5 278 02 47
Мерк Шарп и Доум България ЕООД Тел.: +359 2 819 3737
MSD Belgium
Tél: +32 (0)27766211
Merck Sharp & Dohme s.r.o. Tel.: +420 233 010 111
MSD Pharma Hungary Kft. Tel.: +36 1 8885300
MSD Danmark ApS Tlf: +45 4482 4000
Merck Sharp & Dohme Cyprus Limited Tel: 8007 4433 (+356 99917558)
Merck Sharp & Dohme B.V.
Tel.: 0800 9999000 (+31 23 5153153)
Merck Sharp & Dohme OÜ Tel: +372 6144 200
MSD (Norge) AS Tlf: +47 32 20 73 00
MSD Α.Φ.Β.Ε.Ε
Τηλ: + 30-210 98 97 300
Merck Sharp & Dohme Ges.m.b.H.
Tel: +43 (0) 1 26 044
Ferrer Internacional, S.A. Tel: +34 93 600 37 00
POLPHARMA Biuro Handlowe Sp. z o.o. Tel.: +48 22 364 61 01
Pierre Fabre Médicament Tél: +33 (0) 1 49 10 80 00
Merck Sharp & Dohme, Lda Tel: +351 21 4465700
Merck Sharp & Dohme d.o.o. Tel: + 385 1 6611 333
Merck Sharp & Dohme Romania S.R.L. Tel: + 4021 529 29 00
Merck Sharp & Dohme Ireland (Human Health) Limited
Tel: +353 (0)1 2998700
Merck Sharp & Dohme, inovativna zdravila d.o.o.
Tel: + 386 1 5204201
Vistor hf.
Sími: +354 535 7000
Merck Sharp & Dohme, s. r. o. Tel.: +421 2 58282010
Neopharmed Gentili S.p.A. Tel: +39 02891321
Orion Oyj
Puh./Tel: +358 10 4261
Merck Sharp & Dohme Cyprus Limited
Τηλ: 80000 673 (+357 22866700)
Merck Sharp & Dohme (Sweden) AB Tel: +46 (0)77 5700488
SIA “Merck Sharp & Dohme Latvija”
Tel: +371 67364 224
Merck Sharp & Dohme Ireland (Human Health) Limited
Tel: +353 (0)1 2998700